Exact Mass: 320.1736

Exact Mass Matches: 320.1736

Found 96 metabolites which its exact mass value is equals to given mass value 320.1736, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

NCIOpen2_008298

12alpha-Fluoro-11beta,17beta-dihydroxyandrosta-1,4-dien-3-one

C19H25FO3 (320.1788)

11-Meo-fes

13-fluoro-17-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,14-diol

C19H25FO3 (320.1788)

2-(4-(Piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide

2-[4-(piperidin-3-yl)phenyl]-2H-indazole-7-carboxamide

C19H20N4O (320.1637)

D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors

MMV687706

C19H20N4O (320.1637)

10,11,12-guaianetriol

C15H28O5S (320.1657)

6-O-methyl-3-epidiatretol|lepistamide C|rel-(3R,6R)-3,6-dimethoxy-3-(2-methylpropyl)-6-(phenylmethyl)piperazine-2,5-dione

C17H24N2O4 (320.1736)

FA 22:10

7,10,13,16,19-Docosapentaynoic acid

C22H24O2 (320.1776)

bhas#10

3R-hydroxy-8R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-nonanoic acid

C15H28O7 (320.1835)

An (omega-1)-hydroxy fatty acid ascaroside that is ascr#10 in which the pro-R hydrogen that is beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans as well as the sour paste nematode, Panagrellus redivivus.

bhos#10

3R-hydroxy-9-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-nonanoic acid

C15H28O7 (320.1835)

An omega-hydroxy fatty acid ascaroside that is oscr#10 in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.

(3BETA)-CHOLEST-5-EN-3-OL3,4-DICHLOROBENZOATE

C17H24N2O4 (320.1736)

2-(4-benzylpiperazin-1-yl)-1H-quinazolin-4-one

C19H20N4O (320.1637)

tetrakis(trimethylsilyl)silane

C12H36Si5 (320.1663)

1,3-Bis(4-hydroxyphenyl)adamantane

C22H24O2 (320.1776)

S-1-Cbz-3-Boc-amino pyrrolidine

C17H24N2O4 (320.1736)

4-BENZYL-1-(TERT-BUTOXYCARBONYL)PIPERAZINE-2-CARBOXYLIC ACID

C17H24N2O4 (320.1736)

1-[(TERT-BUTYL)OXYCARBONYL]-3-PYRIDIN-2-YLMETHYLPIPERIDINE-3-CARBOXYLIC ACID

C17H24N2O4 (320.1736)

(R)-1-BOC-4-BENZYLPIPERAZINE-2-CARBOXYLICACID

C17H24N2O4 (320.1736)

Rodocaine

C18H25ClN2O (320.1655)

C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

methyl 3-[4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-y l)phenyl]propanoate

C17H25BO5 (320.1795)

6-(7-methyl-4-piperazin-1-yl-1H-quinazolin-2-ylidene)cyclohexa-2,4-dien-1-one

C19H20N4O (320.1637)

1-benzyl 2-(tert-butyl) tetrahydro-1,2-pyridazinedicarboxylate

C17H24N2O4 (320.1736)

4-{4-[(tert-butoxy)carbonyl]-3-Methylpiperazin-1-yl}benzoic acid

C17H24N2O4 (320.1736)

piperazine-n,n-bis(2-ethanesulfonic acid)-d18

C8D18N2O6S2 (320.1736)

3-(4-N-BOC-PIPERAZIN-1-YL)METHYLBENZOIC ACID

C17H24N2O4 (320.1736)

Piperazine-1,4-dicarboxylic acid benzyl ester tert-butyl ester

C17H24N2O4 (320.1736)

BENZYL(3S)-1-(CYCLOPROPYLAMINO)-2-HYDROXY-1-OXOHEXAN-3-YLCARBAMATE

C17H24N2O4 (320.1736)

TERT-BUTYL-4-CBZ-PIPERAZINE-2-CARBOXYLATE

C17H24N2O4 (320.1736)

METHYL 3-ISOPROPOXY-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE

C17H25BO5 (320.1795)

1,3-Bis[(2,2-dimethyl-1,3-dioxan-5-yl)oxy]-2-propanol

C15H28O7 (320.1835)

(E)-3-[2-(Pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine

C19H20N4O (320.1637)

16-Bromo-1-hexadecanol

C16H33BrO (320.1715)

1-benzyl-3-(tert-butoxycarbonylamino)pyrrolidine-3-carboxylic acid

C17H24N2O4 (320.1736)

1-[(TERT-BUTYL)OXYCARBONYL]-3-PYRIDIN-4-YLMETHYLPIPERIDINE-3-CARBOXYLIC ACID

C17H24N2O4 (320.1736)

tert-butyl [3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl] carbonate

C17H25BO5 (320.1795)

1-Benzyl-4-boc-piperazine-2-carboxylic acid

C17H24N2O4 (320.1736)

(S)-3-BOC-AMINO-2-PIPERIDONE

C17H24N2O4 (320.1736)

N-(1-BOC-PIPERIDIN-4-YL)-2-AMINOBENZOIC ACID

C17H24N2O4 (320.1736)

1-Boc-4-(4-Carboxybenzyl)piperazine

C17H24N2O4 (320.1736)

(R)-1-Cbz-3-Boc-Aminopyrrolidine

C17H24N2O4 (320.1736)

4-fluoro-1-[2-[[(1R,3S)-3-(1,2,4-triazol-1-ylmethyl)cyclopentyl]amino]acetyl]pyrrolidine-2-carbonitrile

C15H21FN6O (320.1761)

2-(4-Boc-Piperazinyl)-2-phenylacetic acid

C17H24N2O4 (320.1736)

1-[(TERT-BUTYL)OXYCARBONYL]-3-PYRIDIN-3-YLMETHYLPIPERIDINE-3-CARBOXYLIC ACID

C17H24N2O4 (320.1736)

2,2-Bis(4-hydroxyphenyl)adamantane

C22H24O2 (320.1776)

Niraparib

MK-4827(Niraparib)

C19H20N4O (320.1637)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XK - Poly (adp-ribose) polymerase (parp) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

1-BOC-3-CBZ-AMINOPYRROLIDINE

C17H24N2O4 (320.1736)

1-BOC-4-(2-METHOXYCARBONYLPHENYL)PIPERA&

C17H24N2O4 (320.1736)

Poly(t-butyl methacrylate)

C18H20N6 (320.1749)

beta-D-Glucopyranose 1-nonanoate

C15H28O7 (320.1835)

D-Glucopyranose 1-nonanoate

C15H28O7 (320.1835)

1-Boc-4-(4-methoxycarbonylphenyl)piperazine

C17H24N2O4 (320.1736)

1-BOC-4-(2-CARBOXYBENZYL)PIPERAZINE

C17H24N2O4 (320.1736)

tert-butyl [4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl] carbonate

C17H25BO5 (320.1795)

TRANS-4-BOC-AMINO-1-BENZYLPYRROLIDINE-3-CARBOXYLIC ACID

C17H24N2O4 (320.1736)

Phenol,4,4-(octahydro-4,7-methano-5H-inden-5-ylidene)bis-

C22H24O2 (320.1776)

2-t-Butoxycarboxyphenylboronic acid, pinacol ester

C17H25BO5 (320.1795)

1-(5-SEC-BUTYL-2-(METHOXYMETHOXY)PHENYL)NAPHTHALENE

C22H24O2 (320.1776)

Imidazo[4,5,1-jk][1,4]benzodiazepin-7(4H)-one, 2-[4-[(dimethylamino)methyl]phenyl]-5,6-dihydro-

C19H20N4O (320.1637)

(R,R)-cis-Diethyl tetrahydro-2,8-chrysenediol

C22H24O2 (320.1776)

(3R,8R)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxynonanoic acid

C15H28O7 (320.1835)

(3R)-9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxynonanoic acid

C15H28O7 (320.1835)

(R)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide

C19H20N4O (320.1637)

L-Seryl-L-seryl-L-lysine

C12H24N4O6 (320.1696)

12alpha-Fluoro-11beta,17beta-dihydroxyandrosta-1,4-dien-3-one

C19H25FO3 (320.1788)

(Z)-2-cyano-3-(7-methyl-2-piperidin-1-ylquinolin-3-yl)prop-2-enamide

C19H20N4O (320.1637)

3-(6-Aminopyridin-3-YL)-N-methyl-N-[(1-methyl-1H-indol-2-YL)methyl]acrylamide

C19H20N4O (320.1637)

1-[5-(4-phenoxyphenyl)-1H-pyrazol-3-yl]piperazine

C19H20N4O (320.1637)

Desulfo-7-deoxycylindrospermopsin

C15H22N5O3+ (320.1723)

11-Meo-fes

C19H25FO3 (320.1788)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

[3-Carboxy-2-(3-carboxy-3-hydroxy-4-methylpentanoyl)oxypropyl]-trimethylazanium

C14H26NO7+ (320.1709)

5,6-dimethyl-N-[2-methyl-2-(4-morpholinyl)propyl]-4-thieno[2,3-d]pyrimidinamine

C16H24N4OS (320.1671)

N-[2-(2-pyridinyl)-3H-benzimidazol-5-yl]cyclohexanecarboxamide

C19H20N4O (320.1637)

Ser-Lys-Ser

C12H24N4O6 (320.1696)

Lys-Ser-Ser

C12H24N4O6 (320.1696)

Himeic acid D

C17H24N2O4 (320.1736)

[(2R,3R,6S)-3-amino-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C16H21FN4O2 (320.1648)

[(2S,3S,6R)-3-amino-6-[2-[4-(3-fluorophenyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C16H21FN4O2 (320.1648)

cyclopropyl-[(1S,5R)-7-[4-(5-pyrimidinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone

C19H20N4O (320.1637)

(9R,17S)-9-fluoro-11,17-dihydroxy-10,17-dimethyl-2,6,7,8,11,12,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one

C19H25FO3 (320.1788)

[1-Carboxy-3-(2,3-diacetyloxypropoxy)propyl]-trimethylazanium

C14H26NO7+ (320.1709)

2-(4-(Piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide

C19H20N4O (320.1637)

D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors

Ser-Ser-Lys

C12H24N4O6 (320.1696)

ABT-107

C19H20N4O (320.1637)

ABT-107 is a selective α7 neuronal nicotinic receptor agonist. ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions[1][2].

(10z)-11-[5-(c-hydroxycarbonimidoyl)-4-oxo-1h-pyridin-2-yl]undec-10-enoic acid

C17H24N2O4 (320.1736)

(3s,6s)-3-benzyl-3,6-dimethoxy-6-(2-methylpropyl)pyrazine-2,5-diol

C17H24N2O4 (320.1736)

(2r)-2-[(3s,3as,5r,8s,8as)-3,8-dimethyl-decahydroazulen-5-yl]-2-hydroxypropoxysulfonic acid

C15H28O5S (320.1657)

3-benzyl-3,6-dimethoxy-6-(2-methylpropyl)pyrazine-2,5-diol

C17H24N2O4 (320.1736)

2-(3,8-dimethyl-decahydroazulen-5-yl)-2-hydroxypropoxysulfonic acid

C15H28O5S (320.1657)

11-[5-(c-hydroxycarbonimidoyl)-4-oxo-1h-pyridin-2-yl]undec-10-enoic acid

C17H24N2O4 (320.1736)